Talaris Therapeutics, Inc.

New Filing

CIK: 0001827506·Biotechnology·DELAWARE·Filed: Oct 7, 2020

Total Offering

$114,999,989

Amount Sold

$114,999,989

Investors

24

First Sale

Sep 22, 2020

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Suzanne Ildstad	Related Person
Nick Galakatos	Related Person
Sandip Agarwala	Related Person
Mark McDade	Related Person
Francois Nader	Related Person
Geoff Mackay	Related Person
Scott Requadt	Related Person

Company

Talaris Therapeutics, Inc.

201 E. JEFFERSON ST., SUITE 110B

LOUISVILLE, KY, 40202

502-569-1059

SEC Filing

0001827506-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.